Evaluation of 143 cases of immune thrombocytopenic purpura with regards to clinical course and response to treatment.

PubWeight™: 0.75^‹?›

🔗 View Article (PMC 4261260)

Published in Eurasian J Med on December 01, 2010

Authors

Murat Albayrak¹, Ozlem Sahin Balcik², Sahika Zeynep Aki³, Ayla Gokmen⁴, Funda Ceran⁵, Osman Yokus⁶, Simten Dagdas⁵, Meltem Ayli⁷, Gulsum Ozet⁵

Author Affiliations

1: Department of Hematology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey.
2: Department of Hematology, Medical School, Fatih University, Ankara, Turkey.
3: Department of Hematology, Medical School, Gazi University, Ankara, Turkey.
4: Department of Hematology, Medical School, Zonguldak Karaelmas University, Zonguldak, Turkey.
5: Department of Hematology, Ankara Numune Education and Research Hospital, Ankara, Turkey.
6: Department of Hematology, Istanbul Okmeydani Education and Research Hospital, Istanbul, Turkey.
7: Department of Hematology, Medical School, Ufuk University, Ankara, Turkey.

Articles cited by this ↗

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood (1996) 7.31

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood (2008) 7.06

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet (2008) 3.74

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol (2003) 3.69

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med (2007) 2.97

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood (2001) 2.96

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood (2004) 2.42

Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol (2003) 2.28

How I treat idiopathic thrombocytopenic purpura (ITP). Blood (2005) 2.05

Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med (2004) 1.69

The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol (2006) 1.58

Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am J Hematol (2005) 1.56

Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults. Br J Haematol (2002) 1.42

Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost (2006) 1.32

Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases. Br J Haematol (1990) 0.95

Definition, diagnosis and treatment of immune thrombocytopenic purpura. Haematologica (2009) 0.81

Articles by these authors ⇆

Serious skin reaction associated with imatinib in a patient with chronic myeloid leukemia. Eurasian J Med (2011) 0.75

Comparative Evaluation of Common Comorbidity Scores and Freiburger Comorbidity Index as Prognostic Variables in a Real Life Multiple Myeloma Population. Indian J Hematol Blood Transfus (2015) 0.75

Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study. Geriatr Gerontol Int (2014) 0.75

The significance of serum transferrin receptor levels in the diagnosis of the coexistence of anemia of chronic disease and iron deficiency anemia. Eurasian J Med (2011) 0.75